Evaluate the Response Rate of Acute Lymphocytic Leukemia Patients to Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone Regimen and Remission Rate to Stay Until the End of the Arbitrary Treatment

DOI: 10.4103/abr.abr_120_16

Keywords: Acute lymphoblastic leukemia, Hyper Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone, recurrence, survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

This study aimed to determine the effect of Hyper-Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone (CVAD) in the treatment of acute lymphoblastic leukemia (ALL) patients and remission duration

Full-Text